Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders
Anna Secher, a scientific director within Obesity and MASH (metabolic dysfunction-associated steatohepatitis) at Novo Nordisk, discussed what is known about how GLP-1R agonists gain access into the brain
GLP-1 medication enhancement One of the fastest-growing uses for Lipo-C is as a complement to semaglutide or tirzepatide treatment
Dulaglutide (Trulicity) Market, 2021-2033 (USD Million) 4.7
How a supplement company became a haven for health misinformation On a Friday afternoon in July, as many New Yorkers fled the scorching city streets, a couple of dozen out-of-towners descended on Times Square
The information contained herein is for informational purposes only and does not establish a doctor-patient relationship